Effect of membrane permeability on inflammation and arterial stiffness: A randomized trial

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 4, 2010, Pages 652-658

  Li, Philip Kam Tao ^a   Cheng, Yuk Lun ^b   Leung, Chi Bon ^a   Szeto, Cheuk Chun ^a   Chow, Kai Ming ^a   Kwan, Bonnie Ching Ha ^a   Ng, Esther Siu Chun ^a   Fok, Queenie Wing Yi ^b   Poon, Yuet Ling ^a   Yu, Alex Wai Yin ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b ALICE HO MIU LING NETHERSOLE HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYAMIDE; POLYSULFONE; TRIACYLGLYCEROL;

ADULT; ALBUMIN BLOOD LEVEL; ARTERIAL STIFFNESS; ARTICLE; ARTIFICIAL KIDNEY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CROSSOVER PROCEDURE; DIABETES MELLITUS; DIALYSIS MEMBRANE; FEMALE; HEMODIALYSIS; HUMAN; INFLAMMATION; KIDNEY FAILURE; LIPID BLOOD LEVEL; MALE; MEMBRANE PERMEABILITY; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; AORTA; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CROSS-OVER STUDIES; ELASTICITY; EQUIPMENT DESIGN; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; KIDNEY FAILURE, CHRONIC; LIPIDS; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; NYLONS; PERMEABILITY; POLYMERS; POROSITY; PULSATILE FLOW; RENAL DIALYSIS; SULFONES; TIME FACTORS;

EID: 77950939089     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.05620809     Document Type: Article

References (21)

1. Seres DS, Strain GW, Hashim SA, Goldberg IJ, Levin NW: Improvement of plasma lipoprotein profiles during high-flux dialysis. J Am Soc Nephrol 3: 1409-1415, 1993
2. Blankestijn PJ, Vos PF, Rabelink TJ, van Rijn HJ, Jansen H, Koomans HA: High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol 5: 1703-1708, 1995
3. Merello Godino JI, Rentero R, Orlandini G, Marcellid D, Ronco C: Results from EuCliD® (European Clinical Dialysis Database): Impact of shifting treatment modality. Int J Artif Organs 25: 1049-1060, 2002 (Pubitemid 36040550)
4. Cheung AK, Levin NW, Greene T, Agodoa L, Bailey J, Beck G, Clark W, Levey AS, Leypoldt JK, Ornt DB, Rocco MV, Schulman G, Schwab S, Teehan B, Eknoyan G: Effects of high-flux hemodialysis on clinical outcomes: Results of the HEMO study. J Am Soc Nephrol 14: 3251-3263, 2003 (Pubitemid 37509301)
5. Kerr PG, Sutherland WH, de Jong S, Vaithalingham I, Williams SM, Walker RJ: The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: A randomized, single-blinded, controlled clinical trial. Am J K dney Dis 49: 533-539, 2007 (Pubitemid 46441602)
6. Chu PL, Chiu YL, Lin JW, Chen SI, Wu KD: Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance. Blood Purif 26: 213-220, 2008 (Pubitemid 351416706)
7. House AA, Wells GA, Donnelly JG, Nadler SP, Hebert PC: Randomized trial of high-flux vs low-flux haemodialysis: Effects on homocysteine and lipids. Nephrol Dial Transplant 15: 1029-1034, 2000
8. Skroeder NR, Kjellstrand P, Holmquist B, Nilsson U, Jacobson SH: Increased amounts of C3a and the terminal complement complex at high dialysis blood-flow: The relation with dialysis efficiency. Nephron 72: 523-529, 1996 (Pubitemid 26098246)
9. Ichihara A, Hayashi M, Ryuzaki M, Handa M, Furukawa T, Saruta T: Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus. Nephrol Dial Transplant 17: 1513-1517, 2002
10. London GM, Marchais SJ, Guerin AP, Metivier F, Adda H, Pannier B: Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients. Kidney Int 63[Suppl 84]: S88-S93, 2003 (Pubitemid 36513384)
11. Tycho Vuurmans JL, Boer WH, Bos WJ, Blankestijn PJ, Koomans HA: Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol 13: 177-183, 2002
12. Tsirpanlis G, Bagos P, Ioannou D, Bleta A, Marinou I, Lagouranis A, Chatzipanagiotou S, Nicolaou C: The variability and accurate assessment of microinflammation in haemodialysis patients. Nephrol Dial Transplant 19: 150-157, 2004 (Pubitemid 38072626)
13. Cheng YL, Choi KS, Yung CU, Wong KM, Chau KF, Li CS, Tsang KY, Wong CK, Tsui YT, Yu AWY: Urea kinetics and clinical biochemistry parameters in patients on twice-weekly hemodialysis. Hong Kong J Nephrol 6: 43-51, 2004 (Pubitemid 38579104)
14. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F: Cardiac and arterial interactions in end-stage renal disease. Kidney Int 50: 600-608, 1996 (Pubitemid 26274391)
15. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55: 648-658, 1999 (Pubitemid 29082891)
16. Stefoni S, Coli L, Cianciolo G, Donati G, Ruggeri G, Ramazzotti E, Pohlmeier R, Lang D: Inflammatory response of a new synthetic dialyzer membrane: A randomized cross-over comparison between polysulfone and helixone. Int J Artif Organs 26: 26-32, 2003 (Pubitemid 36896246)
17. Opatrny K Jr, Krouzecky A, Polanska K, Mares J, Tomsu M, Bowry SK, Vienken J: Does an alternation of dialyzer design and geometry affect biocompatibility parameters? Hemodial Int 10: 201-208, 2006
18. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99: 2434-2439, 1999 (Pubitemid 29218240)
19. Beerenhout CH, Luik AJ, Jeuken-Mertens SG, Bekers O, Menheere P, Hover L, Klaassen L, van der Sande FM, Cheriex EC, Meert N, Leunissen KM, Kooman JP: Predilution on-line haemofiltration vs low-flux haemodialysis: A randomized prospective study. Nephrol Dial Transplant 20: 1155-1163, 2005 (Pubitemid 40862105)
20. Mourad A, Carney S, Gillies A, Jones B, Nanra R, Trevillian P: Acute effect of haemodialysis on arterial stiffness: Membrane bioincompatibility? Nephrol Dial Transplant 19: 2797-2802, 2004 (Pubitemid 39480975)
21. Armitage P, Berry G: Statistical Methods in Medical Research, 3rd Ed., Cambridge, MA, Blackwell, 1994, pp 195-206